A multifaceted ‘omics’ approach for addressing the challenge of antimicrobial resistance

Papers of special note have been highlighted as: • of interest

References

• 1 CDC. Threat Report 2013. Antimicrobial Resistance. www.cdc.gov/drugresistance/threat-report-2013/.• The most up-to-date and comprehensive report describing the antibiotic resistance threats in the USA.
  Google Scholar
• 2 CDC – About Antimicrobial Resistance. www.cdc.gov/drugresistance/about.html.
  Google Scholar
• 3 Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 346(5), 334–339 (2002).
  MedlineGoogle Scholar
• 4 Craig JC, Williams GJ, Jones M et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15,781 febrile illnesses (2010). www.ncbi.nlm.nih.gov/pmc/articles/PMC2857748/.
  Google Scholar
• 5 Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch. Intern. Med. 161(17), 2099–2104 (2001).
  Medline CASGoogle Scholar
• 6 Caterino JM, Hiestand BC, Martin DR. Quality of care in elder emergency department patients with pneumonia: a prospective cohort study. BMC Emerg. Med. 8, 6 (2008).
  MedlineGoogle Scholar
• 7 Houck PM. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 164(6), 637–644 (2004).
  MedlineGoogle Scholar
• 8 Zwart S, Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. BMJ 320(7228), 150–154 (2000).
  Medline CASGoogle Scholar
• 9 Little P. Delayed prescribing of antibiotics for upper respiratory tract infection. BMJ 331(7512), 301–302 (2005).
  MedlineGoogle Scholar
• 10 Spiro DM, Tay K-Y, Arnold DH, Dziura JD, Baker MD, Shapiro ED. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. J. Am. Med. Assoc. 296(10), 1235–1241 (2006).
  CASGoogle Scholar
• 11 Fauci AS, Marston HD. The perpetual challenge of antimicrobial resistance. JAMA 311(18), 1853–1854 (2014).
  Medline CASGoogle Scholar
• 12 Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. J. Am. Med. Assoc. 281(1), 61–66 (1999).
  CASGoogle Scholar
• 13 Hollis A, Ahmed Z. Preserving antibiotics, rationally. N. Engl. J. Med. 369(26), 2474–2476 (2013).
  Medline CASGoogle Scholar
• 14 CDC. Get smart: fast facts about antibiotic resistance. www.cdc.gov/getsmart/antibiotic-use/fast-facts.html.
  Google Scholar
• 15 European Surveillance of Antimicrobial Consumption Network (ESAC-Net). www.ecdc.europa.eu/en/activities/surveillance/ESAC-Net/Pages/index.aspx.
  Google Scholar
• 16 WHO Europe. Data and statistics. www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/data-and-statistics.
  Google Scholar
• 17 WHO. Antimicrobial resistance. www.who.int/mediacentre/factsheets/fs194/en/index.html.
  Google Scholar
• 18 Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century – a clinical super-challenge. N. Engl. J. Med. 360(5), 439–443 (2009).
  Medline CASGoogle Scholar
• 19 Niemz A, Ferguson TM, Boyle DS. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol. 29(5), 240–250 (2011).
  Medline CASGoogle Scholar
• 20 Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab. Chip. 12(14), 2469–2486 (2012).
  Medline CASGoogle Scholar
• 21 Kim KH, Shin JH, Kim SY. The clinical significance of nasopharyngeal carriages in immunocompromised children as assessed. Korean J. Hematol. 44(4), 220–226 (2009).
  Google Scholar
• 22 Shin JH, Han HY, Kim SY. Detection of nasopharyngeal carriages in children by multiplex reverse transcriptase-polymerase chain reaction. Korean J. Pediatr. 52(12), 1358 (2009).
  Google Scholar
• 23 Jung CL, Lee MA, Chung WS. Clinical evaluation of the multiplex PCR Assay for the detection of bacterial pathogens in respiratory specimens from patients with pneumonia. Korean J. Clin. Microbiol. 13(1), 1358–1363 (2010).
  Google Scholar
• 24 Rhedin S, Lindstrand A, Rotzén-Östlund M et al. Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics 133(3), e538–e545 (2014).• Provides a comprehensive evaluation of qPCR tests for common viruses in acute respiratory illness.
  MedlineGoogle Scholar
• 25 Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4(3), 144–154 (2004).
  Medline CASGoogle Scholar
• 26 Spuesens EBM, Fraaij PLA, Visser EG et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: An observational study. PLoS Med. 10(5), e1001444 (2013).
  MedlineGoogle Scholar
• 27 Laxminarayan R, Duse A, Wattal C et al. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 13(12), 1057–1098 (2013).
  MedlineGoogle Scholar
• 28 Aderem A, Adkins JN, Ansong C et al. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. mBio 2(1), e00325–e00310 (2011).
  MedlineGoogle Scholar
• 29 Cooper MA, Shlaes D. Fix the antibiotics pipeline. Nature 472(7341), 32 (2011).
  Medline CASGoogle Scholar
• 30 Press Announcements – new FDA task force will support innovation in antibacterial drug development. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm320643.htm.
  Google Scholar
• 31 Kirby T. Europe to boost development of new antimicrobial drugs. Lancet 379(9833), 2229–2230 (2012).
  MedlineGoogle Scholar
• 32 IMS Institute. Responsible Use of Medicines Report 2012. www.imshealth.com/portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8c22a/?vgnextoid=faf9ee0a8e631410VgnVCM10000076192ca2RCRD&vgnextchannel=736de5fda6370410VgnVCM10000076192ca2RCRD&vgnextfmt=default.
  Google Scholar
• 33 Too Many Antibiotics! Patients and Prescribers Speak Up. www.medscape.com/features/slideshow/public/antibiotic-misuse#1.
  Google Scholar
• 34 Tailored-Treatment. www.tailored-treatment.eu.
  Google Scholar
• 35 Tailored-Treatment. Goals and concept. www.tailored-treatment.eu/?page_id=7.
  Google Scholar
• 36 Laing RE, Hess P, Shen Y, Wang J, Hu SX. The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr. Drug Metab. 12(5), 460–486 (2011).
  Medline CASGoogle Scholar
• 37 Hofker M, Fu J, Wijmenga C. The genome revolution and its role in understanding complex diseases. Biochim. Biophys. Acta. 1842(10), 1889–1895 (2014).
  Medline CASGoogle Scholar
• 38 Chapman SJ, Hill AVS. Human genetic susceptibility to infectious disease. Nat. Rev. Genet. 13(3), 175–188 (2012).
  Medline CASGoogle Scholar
• 39 Emonts M, Hazelzet JA, de Groot R, Hermans PWM. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3(9), 565–577 (2003).
  Medline CASGoogle Scholar
• 40 Brouwer MC, de Gans J, Heckenberg SGB, Zwinderman AH, van der Poll T, van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 9(1), 31–44 (2009).
  Medline CASGoogle Scholar
• 41 Boyd JH, Russell JA, Fjell CD. The meta-genome of sepsis: host genetics, pathogens and the acute immune response. J. Innate Immun. 6(3), 272–283 (2014).
  Medline CASGoogle Scholar
• 42 Ruimy R, Angebault C, Djossou F et al. Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans? J. Infect. Dis. 202(6), 924–934 (2010).
  MedlineGoogle Scholar
• 43 Ge D, Fellay J, Thompson AJ et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461(7262), 399–401 (2009).
  Medline CASGoogle Scholar
• 44 Rauch A, Kutalik Z, Descombes P et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138(4), 1338–1345, 1345.e1–7 (2010).
  Medline CASGoogle Scholar
• 45 Tanaka Y, Nishida N, Sugiyama M et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 41(10), 1105–1109 (2009).
  Medline CASGoogle Scholar
• 46 Ochi H, Maekawa T, Abe H et al. IL-28B predicts response to chronic hepatitis C therapy – fine-mapping and replication study in Asian populations. J. Gen. Virol. 92(Pt 5), 1071–1081 (2011).
  Medline CASGoogle Scholar
• 47 Hetherington S, Hughes AR, Mosteller M et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 359(9312), 1121–1122 (2002).
  Medline CASGoogle Scholar
• 48 Mallal S, Nolan D, Witt C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359(9308), 727–732 (2002).
  Medline CASGoogle Scholar
• 49 Martin AM, Nolan D, Gaudieri S et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc. Natl Acad. Sci. USA 101(12), 4180–4185 (2004).
  Medline CASGoogle Scholar
• 50 Colombo S, Rauch A, Rotger M et al. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir. J. Infect. Dis. 198(6), 864–867 (2008).
  Medline CASGoogle Scholar
• 51 Young B, Squires K, Patel P et al. First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America. AIDS Lond. Engl. 22(13), 1673–1675 (2008).
  Medline CASGoogle Scholar
• 52 Mejias A, Suarez NM, Ramilo O. Detecting specific infections in children through host responses: a paradigm shift. Curr. Opin. Infect. Dis. 27(3), 228–235 (2014).
  MedlineGoogle Scholar
• 53 Ramilo O, Mejías A. Shifting the paradigm: host gene signatures for diagnosis of infectious diseases. Cell Host Microbe 6(3), 199–200 (2009).• These two papers describe the paradigm shift for diagnosing infections using the host differential immune response following the groundbreaking discoveries of their and other research groups.
  Medline CASGoogle Scholar
• 54 Huang Y, Zaas AK, Rao A et al. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. PLoS Genet. 7(8), e1002234 (2011).
  Medline CASGoogle Scholar
• 55 Woods CW, McClain MT, Chen M et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PloS ONE 8(1), e52198 (2013).
  Medline CASGoogle Scholar
• 56 Zaas AK, Chen M, Varkey J et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6(3), 207–217 (2009).
  Medline CASGoogle Scholar
• 57 Ramilo O, Allman W, Chung W et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109(5), 2066–2077 (2007).
  Medline CASGoogle Scholar
• 58 Mahajan P, Ramilo O, Kuppermann N. The future possibilities of diagnostic testing for the evaluation of febrile infants. JAMA Pediatr. 167(10), 888–898 (2013).
  MedlineGoogle Scholar
• 59 Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 9(6), 703–719 (2012).
  Medline CASGoogle Scholar
• 60 Kato K. Impact of the next generation DNA sequencers. Int. J. Clin. Exp. Med. 2(2), 193–202 (2009).
  Medline CASGoogle Scholar
• 61 Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10(1), 57–63 (2009).
  Medline CASGoogle Scholar
• 62 Peng X, Gralinski L, Armour CD et al. Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. mBio 1(5), e00206–10 (2010).
  Medline CASGoogle Scholar
• 63 Gill SR, Pop M, Deboy RT et al. Metagenomic analysis of the human distal gut microbiome. Science 312(5778), 1355–1359 (2006).
  Medline CASGoogle Scholar
• 64 Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13(4), 260–270 (2012).• A comprehensive review that describes the role the human microbiome play in health and disease.
  Medline CASGoogle Scholar
• 65 Albenberg LG, Wu GD. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 146(6), 1564–1572 (2014).
  Medline CASGoogle Scholar
• 66 Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu. Rev. Pathol. 7, 99–122 (2012).
  Medline CASGoogle Scholar
• 67 Madupu R, Szpakowski S, Nelson KE. Microbiome in human health and disease. Sci. Prog. 96(Pt 2), 153–170 (2013).
  Medline CASGoogle Scholar
• 68 Human Microbiome Project DACC – home. www.hmpdacc.org/.
  Google Scholar
• 69 Human Microbiome Project – home. http://commonfund.nih.gov/hmp/index.
  Google Scholar
• 70 Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30(1), 759–795 (2012).
  Medline CASGoogle Scholar
• 71 Pérez-Cobas AE, Gosalbes MJ, Friedrichs A et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. 62(11), 1591–1601 (2012).
  MedlineGoogle Scholar
• 72 Lan Y, Kriete A, Rosen GL. Selecting age-related functional characteristics in the human gut microbiome. Microbiome 1(1), 2 (2013).
  MedlineGoogle Scholar
• 73 Karlsson R, Davidson M, Svensson-Stadler L et al. Strain-level typing and identification of bacteria using mass spectrometry-based proteomics. J. Proteome Res. 11(5), 2710–2720 (2012).
  Medline CASGoogle Scholar
• 74 Chooneea D, Karlsson R, Encheva V, Arnold C, Appleton H, Shah H. Elucidation of the outer membrane proteome of Salmonella enterica serovar Typhimurium utilising a lipid-based protein immobilization technique. BMC Microbiol. 10, 44 (2010).
  MedlineGoogle Scholar
• 75 Lloyd S. Least squares quantization in PCM. IEEE Trans. Inf. Theory 28(2), 129–137 (1982).
  Google Scholar
• 76 Cai H, Ruan P, Ng M, Akutsu T. Feature weight estimation for gene selection: a local hyperlinear learning approach. BMC Bioinformatics 15(1), 70 (2014).
  MedlineGoogle Scholar
• 77 Srikant R, Agrawal R. Mining generalized association rules. Future Gener. Comput. Syst. 13(2–3), 161–180 (1997).
  Google Scholar
• 78 Salzberg SL. C4.5: Programs for Machine Learning by J. Ross Quinlan. Morgan Kaufmann Publishers, Inc., 1993. Mach. Learn. 16(3), 235–240 (1994).
  Google Scholar
• 79 Tenenbaum JB, de Silva V, Langford JC. A global geometric framework for nonlinear dimensionality reduction. Science 290(5500), 2319–2323 (2000).
  Medline CASGoogle Scholar
• 80 Durmuş Tekir SD, Ülgen KÖ. Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era. Biotechnol. J. 8(1), 85–96 (2013).
  Medline CASGoogle Scholar
• 81 InformationWeek. 10 wearable health tech devices to watch. www.informationweek.com/healthcare/mobile-wireless/10-wearable-health-tech-devices-to-watch/240012613.
  Google Scholar